Description
An ERG inhibitor (IC50 = 315 nM); inhibits proliferation of ERG-expressing VCaP prostate, COLO 320 colon, and KG-1 and MOLT-4 leukemia cancer cells (IC50s = 30-400 nM) but LNCaP, LAPC4, and MDA PCa 2b prostate cancer and HUVECs, which do not express ERG (IC50s = >10 µM for all); reduces tumor growth in a VCaP mouse xenograft model at 100 and 150 mg/kg
Formal name: 1-[2-(2-thiazolyl)diazenyl]-2-naphthalenol
Synonyms: NSC 139021
Molecular weight: 255.3
CAS: 1147-56-4
Purity: ≥98%
Formulation: A solid